Dyadic International, Inc. (NASDAQ:DYAI) headquartered in Jupiter, will host a conference call for the investment community to discuss the 3Q20 earnings result on 12th November 2020 at 5:00 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.dyadic.com
Individuals interested in participating in the audio call may dial the listen only number(s) (877) 407-8033 Toll Free, (United States) or +(201) 689-8033 (International)
Earnings Expectation
Dyadic International, Inc. is expected to report third quarter earnings results, after market close, on Thursday 12th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.08 per share from revenue of $ 0.30 million. Looking ahead, the full year loss are expected at $ 0.33 per share on the revenues of $ 1.00 million.
Dyadic International, Inc., a biotechnology platform company, engages in the development, production, and sale of enzymes and other proteins in the United States. It utilizes its patented and proprietary C1 technology and other technologies to conduct research, development, and commercial production of human and animal vaccines, monoclonal antibodies, bi-specific antibodies, fab antibody fragments, FC-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. Dyadic International, Inc.
